Margaux Mekkan-Bouv Hez, Lea Derbey, Louis de Mestier, Lorenzo D, Thomas Walter, M Perrier, Guillaume Cadiot, B Goichot, M Pracht, A Lièvre, Romain Coriat, Sophie Valancot, Rosine Guimbaud, Nicolas Carrere, O Bacoeur-Ouzillou, G Belleannée, Denis Smith, S Laboureau, Sophie Hescot, Catherine Julie, M P Teissier, Jeremie Thereaux, A Ferru, C Evrard, Muriel Mathonnet, Niki Christou
INTRODUCTION: Duodenal neuroendocrine tumours (D-NETs) have a low incidence; however, their diagnosis has been increasing. Features such as tumour location, size, type, histological grade, and stage were used to adapt the treatment to either endoscopic (ER) or surgical (SR) resections. There is no consensus regarding the definitive treatment. The authors' study aimed to describe the management of non-metastatic, well-differentiated D-NETs in France and its impact on patient survival. METHODS: A registry-based multicenter study using prospectively collected data between 2000 and 2019, including all patients managed for non-metastatic G1 and G2 D-NETs, was conducted in the GTE group...
April 3, 2024: International Journal of Surgery